PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 126 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $148,800 | -53.7% | 56,578 | -37.8% | 0.00% | -100.0% |
| Q2 2023 | $321,184 | +516.9% | 90,987 | +440.0% | 0.00% | – |
| Q1 2023 | $52,066 | -31.2% | 16,850 | -5.8% | 0.00% | – |
| Q4 2022 | $75,687 | -34.8% | 17,893 | -53.2% | 0.00% | – |
| Q4 2021 | $116,000 | -83.3% | 38,201 | -61.6% | 0.00% | -100.0% |
| Q3 2021 | $696,000 | -1.4% | 99,357 | +29.2% | 0.00% | -33.3% |
| Q2 2021 | $706,000 | +82.9% | 76,926 | +93.8% | 0.00% | +50.0% |
| Q1 2021 | $386,000 | -30.5% | 39,700 | -26.7% | 0.00% | -50.0% |
| Q4 2020 | $555,000 | +178.9% | 54,128 | +174.7% | 0.00% | +33.3% |
| Q3 2020 | $199,000 | +14.4% | 19,703 | +18.3% | 0.00% | 0.0% |
| Q2 2020 | $174,000 | -84.8% | 16,658 | -87.3% | 0.00% | -57.1% |
| Q4 2019 | $1,144,000 | -37.5% | 130,773 | -23.0% | 0.01% | -56.2% |
| Q3 2019 | $1,829,000 | -23.5% | 169,927 | -9.7% | 0.02% | -30.4% |
| Q2 2019 | $2,391,000 | +110.5% | 188,152 | +542.4% | 0.02% | +91.7% |
| Q1 2019 | $1,136,000 | +81.5% | 29,290 | -4.8% | 0.01% | +71.4% |
| Q4 2018 | $626,000 | -66.0% | 30,765 | -23.5% | 0.01% | -68.2% |
| Q3 2018 | $1,843,000 | +75.5% | 40,191 | +278.2% | 0.02% | +22.2% |
| Q4 2017 | $1,050,000 | +1.2% | 10,626 | +22.5% | 0.02% | -10.0% |
| Q3 2017 | $1,038,000 | -48.2% | 8,671 | -62.2% | 0.02% | -48.7% |
| Q2 2017 | $2,004,000 | +136.6% | 22,934 | +0.8% | 0.04% | +69.6% |
| Q1 2017 | $847,000 | +14.3% | 22,763 | -5.7% | 0.02% | -23.3% |
| Q4 2016 | $741,000 | +198.8% | 24,134 | +551.6% | 0.03% | +87.5% |
| Q3 2016 | $248,000 | -77.9% | 3,704 | -61.5% | 0.02% | -95.6% |
| Q2 2015 | $1,124,000 | – | 9,627 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HARVARD MANAGEMENT CO INC | 600,000 | $45,216,000 | 3.56% |
| Avalon Global Asset Management LLC | 32,900 | $2,479,000 | 1.79% |
| CORNERSTONE CAPITAL MANAGEMENT LLC | 495,145 | $37,314,000 | 1.58% |
| BB BIOTECH AG | 521,991 | $39,337,000 | 1.25% |
| WEATHERBIE CAPITAL, LLC | 137,041 | $10,327,000 | 1.20% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $428,527,000 | 1.19% |
| TOBAM | 318,384 | $23,994,000 | 0.94% |
| Orbimed Advisors | 1,195,500 | $90,093,000 | 0.91% |
| Capital International Sarl | 109,405 | $8,245,000 | 0.74% |
| CAPITAL INTERNATIONAL LTD /CA/ | 145,697 | $10,980,000 | 0.73% |